Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Document › Details

InflaRx N.V.. (5/17/18). "Press Release: InflaRx N.V. Reports First Quarter 2018 Financial & Operating Results". Jena.

Organisations Organisation InflaRx N.V. (Nasdaq Global Select Market: IFRX)
  Group InflaRx (Group)
  Organisation 2 LifeSci Advisors LLC
  Group LifeSci (Group)
Products Product IFX-1 (InflaRx)
  Product 2 clinical research
Index term Index term InflaRx–SEVERAL: investment, 201805 primary public offering $51m+$7.65m w 1.5m+225k common shares at $34/share
Persons Person Christ, Arnd (InflaRx 201506– CFO before Proteros + MediGene + NovImmune + Probiodrug + Hoechst)
  Person 2 Gibney, Tony (InflaRx 201802– Non-Executive Board Director before Leerink Partners + Merrill Lynch + Lehman Brothers)
     


   
Record changed: 2018-06-07

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for InflaRx (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top